Headache & Migraine
Literature Review
Headache for inpatients with COVID-19 may predict better survival
Headache arising secondary to COVID-19 infection may be a marker of enhanced likelihood of survival.
Expert Perspective
In the Quest for Migraine Relief, The Search for Biomarkers Intensifies
News
Will the headache field embrace rofecoxib?
The drug formerly known as Vioxx, withdrawn in 2004 over cardiovascular safety concerns, may be given new life as an acute treatment for migraine...
Conference Coverage
Are headache clinical trials representative of the general patient population?
Conference Coverage
Promising new tool for better migraine management in primary care
The medical record “best-practice alert,” aims at reducing specialist referrals and MRI studies.
Conference Coverage
Twin study offers new insight into genetics of migraine
Findings suggest that the prenatal environment – not just genetics – may explain higher rates in females.
News
Acupuncture deep needling technique points to greater tension headache relief
At this depth, acupuncture promotes deqi sensation, which is considered key to successful acupuncture treatment in traditional Chinese acupuncture...
Conference Coverage
Migraine-related stigma is common and underappreciated
Even those experiencing only a few headaches per month said they experienced negative attitudes from others about migraine.
Conference Coverage
Autoimmune disorder drugs top list of meds linked to headache
Antivirals and pulmonary arterial vasodilators are also troublesome, database suggests.
Conference Coverage
Recommended headache treatments get mixed reception in EDs
Opioid prescriptions have declined but guideline-supported triptans and corticosteroids aren’t filling the gap.